97 Brown, N.O., A.K. Patnaik, and E.G. MacEwen. 1985. Canine hemangiosarcoma: Retrospective analysis of 104 cases. J Am Vet Med Assoc 186:56–58.
98 Brunnert, S.R., L.A. Dee, A.J. Herron, et al. 1992. Gastric extramedullary plasmacytoma in a dog. J Am Vet Med Assoc 200:1501–1502.
99 Buchholz, J., R. Hagen, C. Leo, et al. 2009. 3D conformal radiation therapy for palliative treatment of canine nasal tumors. Vet Radiol Ultrasound 50:679–683.
100 Budreckis, D.M., B.A. Byrne, R.E. Pollard, et al. 2015. Bacterial urinary tract infections associated with transitional cell carcinoma in dogs. J Vet Intern Med 29:828–833.
101 Buijtels, J.J., I.A. Kurvers, S. Galac, et al. 2006. [Transdermal carbimazole for the treatment of feline hyperthyroidism]. Tijdschr Diergeneeskd 131:478–482.
102 Bulakowski, E.J., J.C. Philibert, S. Siegel, et al. 2008. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001–2006). J Am Vet Med Assoc 233:122–128.
103 Buracco, P., E. Morello, M. Martano, et al. 2002. Pasteurized tumoral autograft as a novel procedure for limb sparing in the dog: A clinical report. Vet Surg 31:525–532.
104 Burton, J.H., E. Garrett‐Mayer, and D.H. Thamm. 2013. Evaluation of a 15‐week CHOP protocol for the treatment of canine multicentric lymphoma. Vet Comp Oncol 11:306–315.
105 Burton, J.H., L. Mitchell, D.H. Thamm, et al. 2011. Low‐dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma. J Vet Intern Med 25:920–926.
106 Burton, J.H., R.O. Venable, D.M. Vail, et al. 2015. Pulse‐administered toceranib phosphate plus lomustine for treatment of unresectable mast cell tumors in dogs. J Vet Intern Med 29:1098–1104.
107 Cahalane, A.K., S. Payne, L.G. Barber, et al. 2004. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994–2002). J Am Vet Med Assoc 225:401–408.
108 Campos, M., R. Ducatelle, G. Rutteman, et al. 2014. Clinical, pathologic, and immunohistochemical prognostic factors in dogs with thyroid carcinoma. J Vet Intern Med 28:1805–1813.
109 Cancedda, S., L. Marconato, V. Meier, et al. 2016a. Hypofractionated radiotherapy for macroscopic canine soft tissue sarcoma: A retrospective study of 50 cases treated with a 5 × 6 gy protocol with or without metronomic chemotherapy. Vet Radiol Ultrasound 57(1):75–83.
110 Cancedda, S., C. Rohrer Bley, L. Aresu, et al. 2016b. Efficacy and side effects of radiation therapy in comparison with radiation therapy and temozolomide in the treatment of measurable canine malignant melanoma. Vet Comp Oncol 14(4):e146–e157.
111 Cancedda, S., S. Sabattini, G. Bettini, et al. 2015. Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma. Vet Radiol Ultrasound 56:335–343.
112 Cannon, C., A. Borgatti, M. Henson, et al. 2015. Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma. J Small Anim Pract 56:425–429.
113 Carberry, C.A., J.A. Glanders, H.J. Harvey, et al. 1988. Salivary gland tumors in dogs and cats: A literature and case review. J Am Anim Hosp Assoc 24:561–567.
114 Carlsten, K.S., C.A. London, S. Haney, et al. 2012. Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors. J Vet Intern Med 26:135–141.
115 Carter, R.F., C.K. Harris, S.J. Withrow, et al. 1987. Chemotherapy of canine lymphoma with histopathological correlation: Doxorubicin alone compared to COP as first treatment regimen. J Am Anim Hosp Assoc 23:221–225.
116 Carver, J.R., A. Kapatkin, and A.K. Patnaik. 1995. A comparison of medullary thyroid carcinoma and thyroid adenocarcinoma in dogs: A retrospective study of 38 cases. Vet Surg 24:315–319.
117 Case, J.B., C.M. Macphail, and S.J. Withrow. 2012. Anatomic distribution and clinical findings of intermuscular lipomas in 17 dogs (2005–2010). J Am Anim Hosp Assoc 48:245–249.
118 Cavalcanti, J.V., M.P. Moura, and F.O. Monteiro. 2014. Thymoma associated with exfoliative dermatitis in a cat. J Feline Med Surg 16:1020–1023.
119 Cemezar, M., J.A. Avgustin, D. Pavlin, et al. 2017. Efficacy and safety of electrochemotherapy combined with peritumoral IL‐12 gene electrotransfer of canine mast cell tumors. Vet Comp Oncol 15:641–654.
120 Cerf, D.J. and E.C. Lindquist. 2012. Palliative ultrasound‐guided endoscopic diode laser ablation of transitional cell carcinomas of the lower urinary tract in dogs. J Am Vet Med Assoc 240:51–60.
121 Chaffin, K. and D.E. Thrall. 2002. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis. Vet Radiol Ultrasound 43:392–395.
122 Chakraborty, S., L. Balogh, T. Das, et al. 2016. Evaluation of 177Lu‐EDTMP in dogs with spontaneous tumor involving bone: Pharmacokinetics, dosimetry and therapeutic efficacy. Curr Radiopharm 9:64–70.
123 Charney, S.C., P.J. Bergman, J.A. Mcknight, et al. 2005. Evaluation of intracavitary mitoxantrone and carboplatin for treatment of carcinomatosis, sarcomatosis and mesothelioma, with or without malignant effusions: A retrospective analysis of 12 cases (1997–2002). Vet Comp Oncol 3:171–181.
124 Chase, D., J. Bray, A. Ide, et al. 2009. Outcome following removal of canine spindle cell tumours in first opinion practice: 104 cases. J Small Anim Pract 50:568–574.
125 Cheli, R., F. Addis, C.M. Mortellaro, et al. 1987. Photodynamic therapy of spontaneous animal tumors using the active component of hematoporphyrin derivative (DHE) as photosensitizing drug: Clinical results. Cancer Lett 38:101–105.
126 Chen, C.L., M.H. Sun, D.C. Tan, et al. 2004. Comparison of pelvic transarterial chemoembolization with lipiodol ultra‐fluid carboplatin and transarterial carboplatin through experiment in dogs. Ai Zheng 23:1405–1408.
127 Chun, R. 2009. Lymphoma: Which chemotherapy protocol and why? Top Companion Anim Med 24:157–162.
128 Chun, R., L.D. Garrett, C. Henry, et al. 2005. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma. J Am Anim Hosp Assoc 41:382–387.
129 Chun, R., L.D. Garrett, and D.M. Vail. 2000. Evaluation of a high‐dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 14:120–124.
130 Church, E.M., C.J. Mehlhaff, and A.K. Patnaik. 1987. Colorectal adenocarcinoma in dogs: 78 cases (1973–1984). J Am Vet Med Assoc 191:727–730.
131 Ciekot, P.A., B.E. Powers, S.J. Withrow, et al. 1994. Histologically low‐grade, yet biologically high‐grade, fibrosarcomas of the mandible and maxilla in dogs: 25 cases (1982–1991). J Am Vet Med Assoc 204:610–615.
132 Clemente, M., P.J. de Andres, L. Pena, et al. 2009. Survival time of dogs with inflammatory mammary cancer treated with palliative therapy alone or palliative therapy plus chemotherapy. Vet Rec 165:78–81.
133 Clifford, C.A., K.A. Skorupski, and P.F. Moore. 2012. Histiocytic diseases. In Withrow and MacEwen’s Small Animal Clinical Oncology, 5th edition. S.J. Withrow, D.M. Vail, and R. Page, editors. Philadelphia: W. B. Saunders.
134 Closa, J.M., A. Font, and J. Mascort. 1999. Pericardial mesothelioma in a dog: Long‐term survival after pericardiectomy in combination with chemotherapy. J Small Anim Pract 40:383–386.
135 Cohen, M., J.C. Wright, W.R. Brawner, et al. 2001. Use of surgery and electron beam irradiation, with or without chemotherapy, for treatment of vaccine‐associated sarcomas in cats: 78 cases (1996–2000). J Am Vet Med Assoc 219:1582–1589.
136 Coleman, K.A., A.C. Berent, and C.W. Weisse. 2014. Endoscopic mucosal resection and snare polypectomy for treatment of a colorectal